Reply to comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

Authors

  • Matthew R. Cooperberg MD, MPH,

    1. Department of Urology UCSF Helen Diller Family, Comprehensive Cancer Center San Francisco, California
    2. Department of Epidemiology and Biostatistics, Memorial-Sloan Kettering Cancer Center, New York, New York
    Search for more papers by this author
  • Peter R. Carroll MD, MPH,

    1. Department of Urology UCSF Helen Diller Family, Comprehensive Cancer Center San Francisco, California
    2. Department of Epidemiology and Biostatistics, Memorial-Sloan Kettering Cancer Center, New York, New York
    Search for more papers by this author
  • Andrew J. Vickers PhD

    1. Department of Urology UCSF Helen Diller Family, Comprehensive Cancer Center San Francisco, California
    2. Department of Epidemiology and Biostatistics, Memorial-Sloan Kettering Cancer Center, New York, New York
    Search for more papers by this author

No abstract is available for this article.

Ancillary